Michelle Mason, PA
Surgical · Grand Junction, CONPI 1548842065
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Axonics, Inc. at 37.0% of the total. Reporting peaked in 2023 at $3,635 and has fallen 74.3% since, to $933 in 2025. Among surgical clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $59.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Medtronic$2K
- Dendreon Pharmaceuticals LLC$310
- Bayer$197
- Procept Biorobotics Corporation$189
- Calyxo, Inc.$168
- plus $640 from 15 others
What the payments were for
- Travel & lodging$2,50847%
- Food & beverage$2,87153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 25 | $1,988 |
| Medtronic | 20 | $1,887 |
| Dendreon Pharmaceuticals LLC | 6 | $310 |
| Bayer | 6 | $197 |
| Procept Biorobotics Corporation | 2 | $189 |
| Calyxo, Inc. | 2 | $168 |
| Sumitomo Pharma America, Inc. | 6 | $105 |
| Astellas Pharma US Inc | 5 | $96 |
| Johnson & Johnson | 5 | $78 |
| Boston Scientific | 1 | $68 |
| Merck | 2 | $50 |
| Novartis | 2 | $47 |
| Innovation Technologies Inc | 1 | $37 |
| Steris Corporation | 1 | $36 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| 180 Medical, Inc. | 1 | $20 |
| Coloplast | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Foundation Medicine, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,358
- Axonics$1,228
- Bulkamid$222
- AquaBeam Robotic System$150
- CVAC Aspiration System$140
- Axonics r-SNM System$117
- Nubeqa$116
- Xofigo$116
- PROVENGE$110
How this compares
$5,379 in reported general payments places this provider in the 95th percentile of 495 surgical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 142 | $90,871 |
| GemtesaVibegron | 23 | $19,819 |
| Estradiol | 141 | $8,030 |
| EstringEstradiol | 12 | $6,404 |
| Methenamine Hippurate | 73 | $4,225 |
| Solifenacin Succinate | 35 | $2,350 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 12 | $2,261 |
| Testosterone | 11 | $1,153 |
| Testosterone Cypionate | 34 | $1,042 |
| ProgesteroneProgesterone, Micronized | 19 | $834 |
| Tamsulosin Hcl | 105 | $693 |
| Trimethoprim | 11 | $632 |
| NitrofurantoinNitrofurantoin Macrocrystal | 27 | $618 |
| Oxybutynin Chloride | 31 | $584 |
| Cephalexin | 72 | $575 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $96 | $90,871142 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $105 | $19,81923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 495 surgical providers in Colorado.
Other surgical in Grand Junction
- Lauren HolmesGrand Junction$6K
- Amanda WelcerGrand Junction$3K
- Danielle VesthGrand Junction$3K
- Jordan CampbellGrand Junction$2K
- Michael WellsAurora$26K
- Charles EttelsonDenver$24K
- Joshua CrossLakewood$17K
- Mitchell EricksonAurora$16K
- Tim FilzenColorado Springs$13K
- Charles JenningsThornton$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.